CAR T Cells to Target GD2 for DMG

Clinical trial NCT05544526 · RECRUITING

Trial details

NCT number: NCT05544526
Sponsor: University College, London
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Midline Glioma, H3 K27M-Mutant

Start date: 2023-08-15
Primary completion: 2027-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.